RFK Jr. Orders FDA Review of Abortion Pill Following New Safety Concerns
U.S. Health Secretary Robert F. Kennedy Jr. announced on May 14 that he has directed the Food and Drug Administration (FDA) to conduct a comprehensive review of the abortion pill mifepristone, citing newly surfaced data indicating a significantly higher rate of serious adverse events than previously reported.
